American Journal of Obstetrics & Gynecology
Volume 192, Issue 2 , Pages 604-609, February 2005

Persistent elevation of cell-free fetal DNA levels in maternal plasma after selective laser coagulation of chorionic plate anastomoses in severe midgestational twin-twin transfusion syndrome

  • Tuangsit Wataganara, MD

      Affiliations

    • Division of Genetics, Department of Pediatrics, Obstetrics and Gynecology, Tufts-New England Medical Center, Tufts University School of Medicine, Boston, Mass
  • ,
  • Eduard Gratacos, MD

      Affiliations

    • Fetal Medicine Unit, Department of Obstetrics and Gynecology, Hospital Universitari Vall d'Hebron, Barcelona, Spain
  • ,
  • Jacques Jani, MD

      Affiliations

    • Department of Obstetrics and Gynaecology, University Hospital Gasthuisberg, Leuven, Belgium
  • ,
  • Jorge Becker, MD

      Affiliations

    • Fetal Medicine Unit, Department of Obstetrics and Gynecology, Hospital Universitari Vall d'Hebron, Barcelona, Spain
  • ,
  • Liesbeth Lewi, MD

      Affiliations

    • Department of Obstetrics and Gynaecology, University Hospital Gasthuisberg, Leuven, Belgium
  • ,
  • Lisa M. Sullivan, PhD

      Affiliations

    • Department of Biostatistics, Boston University, Boston, Mass
  • ,
  • Diana W. Bianchi, MD

      Affiliations

    • Division of Genetics, Department of Pediatrics, Obstetrics and Gynecology, Tufts-New England Medical Center, Tufts University School of Medicine, Boston, Mass
    • Corresponding Author InformationReprint request: Diana W. Bianchi, MD, Division of Genetics, Departments of Pediatrics, Obstetrics and Gynecology, Tufts-New England Medical Center, 750 Washington St, Box 394, Tufts-NEMC, Boston, MA 02111.
  • ,
  • Jan A. Deprest, MD, PhD

      Affiliations

    • Department of Obstetrics and Gynaecology, University Hospital Gasthuisberg, Leuven, Belgium

Received 14 March 2004; received in revised form 11 June 2004

Objective

This study was undertaken to determine whether laser thermocoagulation for twin-twin transfusion syndrome (TTTS) causes increased cell-free fetal DNA levels in maternal plasma, potentially as a result of placental injury.

Study design

We enrolled 34 patients with twin pregnancies complicated by severe TTTS who underwent fetoscopic selective laser ablation of placental vascular anastomoses. Blood samples were drawn before and sequentially after the procedure. Fetal DNA in maternal plasma was quantified by polymerase chain reaction amplification of a Y-chromosome sequence.

Results

Compared with baseline, median elevations of fetal DNA levels were 0.8% at 30 minutes (P=.32), 15.8% at 60 minutes (P=.1), 179.5% at 24 hours (P=.003), and 172.9% at 48 hours (P=.003). Factors associated with increased fetal DNA levels at 24 hours after procedure included longer operation time, higher number of vessels ablated, and subsequent in utero fetal death (P=.01, .04, and .04, respectively).

Conclusions

Persistent elevation of fetal DNA levels in maternal plasma after laser ablation suggests that circulating fetal DNA could derive from placental injury. Plasma fetal DNA analysis may be an additional prognostic marker for fetal outcome after laser therapy.

Key words: Cell-free fetal DNA, Twin-twin transfusion syndrome, Fetoscopic laser ablation, Placental pathology, In utero fetal death

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 The Maternal-Fetal Medicine Fellowship (TW) was supported in part by the Anandamahidol Foundation, Thailand. The fellowship (JJ) and the clinical trials were supported by the European Commission (EURO TWIN 2 TWIN, GLC1-CT-2002-01632). L. Lewi is a recipient of a doctoral fellowship of the Flemish Government (VIS/00/009). Funding was also received from The Spanish Fondo de Investigaciones Cientificas (FIS 02/0738 to EG) and the United States National Institutes of Health (N01-HD43204 and R01-HD42053 to DWB).

PII: S0002-9378(04)00777-X

doi:10.1016/j.ajog.2004.07.019

American Journal of Obstetrics & Gynecology
Volume 192, Issue 2 , Pages 604-609, February 2005